Prof. Abdullah Fayez AlAsmari | أ.د. عبدالله بن فايز الأسمري

Prof. Abdullah AlAsmari earned his B.Sc. in Pharmaceutical Sciences from King Saud University (KSU) in 2011 (GPA 4.31/5.00, Second-Class Honors), then joined the Saudi Food and Drug Authority as a Senior Pharmacist in the Executive Directorate of Pharmacovigilance and Crisis Management (2011-2012). He earned his Ph.D. in Pharmaceutical Sciences from Auburn University's Harrison College of Pharmacy (2013-2017), with a dissertation on "Myocardial Ischemia/Reperfusion Injury and Cardioprotection: Novel Roles of Frataxin and Uridine Triphosphate" under Prof. Jianzhong Shen supervision. During his doctoral training, he served as a judge for Auburn's graduate research symposium, won second place for best scientific poster (2014), and received the Auburn University Graduate School Travel Award (2016).

He joined KSU's Department of Pharmacology and Toxicology as Assistant Professor in 2017, chaired the department from 2019-2023, and was promoted to Associate Professor (2021) and Professor (2025). From 2023-2025, he served as the Vice Dean for Programs and Initiatives at the Deanship of Graduate Studies. His research addresses cardioprotection mechanisms in ischemia-reperfusion injury, myocardial bioenergetics, HIF-1a and purinergic signaling, diabetic/hyperglycemic molecular pathways, and anticancer drug-induced cardiotoxicity, supported by grants from KSU's Deanship of Scientific Research, the Saudi National Institute of Health, and the Prince Naif Health Research Center. He has authored over 200 peer-reviewed publications and book chapters, ranks among the top 2\% of researchers worldwide (Elsevier-Stanford, 2024 and 2025), and has supervised more than 25 graduate and undergraduate students. He is a registered consultant pharmacist with SCFHS, serves on the Saudi Pharmacist Licensure Examination committees, reviews for multiple international journals, and holds executive leadership certifications from Harvard (2025) and Oxford (2024).